Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir.
Sign Up to like & getrecommendations! Published in 2021 at "Antiviral research"
DOI: 10.1016/j.antiviral.2021.105035
Abstract: Pimodivir exerts an antiviral effect on the early stages of influenza A virus replication by inhibiting the cap-binding function of polymerase basic protein 2 (PB2). In this study, we used a combination of sequence analysis… read more here.
Keywords: pimodivir susceptibility; susceptibility; influenza viruses; viruses pb2 ... See more keywords